期刊文献+

同型半胱氨酸水平与慢性心力衰竭的相关性研究 被引量:1

Study on the relationship between homocysteine and chronic heart failure
下载PDF
导出
摘要 目的:探讨血清同型半胱氨酸(Hcy)水平与慢性心力衰竭的关系。方法:2015年5月-2018年5月收治慢性心力衰竭患者110例,作为观察组;选同时期非心衰患者50例,作对照组。比较两组N端前脑钠肽(NTpro-BNP)、Hcy水平及左心射血分数。结果:观察组NTpro-BNP及Hcy水平均明显高于对照组,差异有统计学意义(P<0.05);心功能Ⅱ级与Ⅳ级左心射血分数比较,差异有统计学意义(P<0.05);观察组NTpro-BNP与血浆Hcy水平明显呈正相关(P<0.05)。结论:血浆Hcy水平与心力衰竭存在相关性,可能参与心力衰竭的病理生理过程,成为心力衰竭的治疗靶点及诊断标志物。 Objective:To explore the relationship between serum homocysteine(Hcy)level and chronic heart failure.Methods:From May 2015 to May 2018,110 patients with chronic heart failure were selected as the observation group.50 patients with non-heart failure at the same period were selected as the control group.The NTpro-BNP,Hcy levels and left heart ejection fraction were compared between the two groups.Results:The levels of NTpro-BNP and Hcy in the observation group were significantly higher than those in the control group,the differences were statistically significant(P<0.05).The difference of left ventricular ejection fraction between gradeⅡand gradeⅣof cardiac function was statistically significant(P<0.05).NTpro-BNP in the observation group was positively correlated with plasma Hcy levels(P<0.05).Conclusion:There is a correlation between plasma Hcy level and heart failure,which may participate in the pathophysiological process of heart failure,and become a therapeutic target and diagnostic marker for heart failure.
作者 白艳艳 刘成 史骏 冯六六 Bai Yanyan;Liu Cheng;Shi Jun;Feng Liuliu(Department of Cardiology,Shidong Hospital of Yangpu District,Shanghai,Shanghai 200438)
出处 《中国社区医师》 2020年第32期16-17,共2页 Chinese Community Doctors
关键词 心力衰竭 同型半胱氨酸 NTpro-BNP Chronic cheart failure Homocysteine,NTpro-BNP
  • 相关文献

参考文献1

二级参考文献17

  • 1Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is !t[J]. Eur He,art J,2001,22.:623-626.
  • 2中华匠学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断和治疗建议[J].中华心血管病杂志,2007,35(12):1076-1095.
  • 3The Task Force for the diagnosis and treatment of chronic heart fail- ure of the European Society of Cardiology. Guidelines for thediagnosis and treatment of chronicheart failure: eecutive summary ( Update 2005) [J]. Eur Heart J,2005,26:1115-1140.
  • 4Boushey C J, Bercsford SA, Omenn GS, et al. A quantitative assess- ment of plasma homocysteine as a risk factor for vascular disease. Prebable benefits of increasing lic acid intakes[ J]. JAMA, 1995,274 (13) :1049-1057.
  • 5Parnetti L. Hyperhomocysteinemia: a risk factor for cerebrovascular disease[J]. Clin Exp Hypertens,2002,24(7-8) :501-509.
  • 6Herrmann W. Significance of hyperhomocysteinemia [ J ]. Clin Lab, 2006,52(7-8) :367-374.
  • 7Kojoglanian SA,Jorgensen MB, Wolde-Tsadik G, et al. Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH) [ J ]. Am Heart J.2003.146(6) :1077-1081.
  • 8Bots ML Launer LJ, Lindemans J, et al. Homocysteine and short- term risk"of myocardial infarction and stroke in the elderly: the Rot- terdam Study[ J]. Arch Intern Med, 1999,159 ( 1 ) :38-44.
  • 9Vizzardi E, Bonadei I,Zanini G, et al. Homocysteine and heart fail- ure:an overview [ J ]. Recent Pat Cardiovasc Drug Discov,2009,1 : 15-21.
  • 10Hum phrey LL, Fu R, Rogers K, et al. Homocysteine level and coro- nary heart disease incidence: a system aticreview and meta-analysis [ J]. Mayo Clin Proc,2008,83:1203-1212.

共引文献12

同被引文献68

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部